HCT116-GFP Cells
CAD$1,104.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | HCT116-GFP is a genetically modified derivative of the human colorectal carcinoma cell line HCT116, engineered to constitutively express green fluorescent protein (GFP). The parental HCT116 line originates from a colon carcinoma of an adult patient and is widely used as a model of mismatch repair–deficient (MMR-deficient) colorectal cancer. Cytogenetic analyses have shown that HCT116 cells typically exhibit a near-diploid karyotype with defined chromosomal alterations, including structural rearrangements and copy number variations characteristic of microsatellite instability–positive colorectal tumors. Introduction of the GFP reporter gene enables real-time visualization of cellular behavior without substantially altering the intrinsic genetic and phenotypic properties of the parental line. The GFP labeling in HCT116-GFP cells is commonly achieved through stable transfection, resulting in uniform fluorescence that facilitates live-cell imaging, cell tracking, and quantitative analysis of proliferation, migration, and tumor growth dynamics. This modification is particularly valuable in in vitro assays and in vivo xenograft models, where GFP expression allows non-invasive monitoring of tumor progression, metastatic dissemination, and response to therapeutic interventions. Fluorescence-based phenotypic profiling approaches have demonstrated that colon cancer cell lines, including HCT116, exhibit distinct intracellular signatures that can be captured through imaging-based methodologies, supporting the utility of fluorescent reporters such as GFP for high-content screening applications. HCT116-GFP serves as a robust tool for investigating colorectal cancer biology, enabling detailed analysis of tumor cell behavior, microenvironmental interactions, and therapeutic efficacy in both basic and translational research contexts. |
|---|---|
| Organism | Human |
| Tissue | Colon |
| Disease | Colon carcinoma |
| Synonyms | HCT-116, HCT.116, HCT_116, HCT116, HCT116wt, HCT-116/P, HCT-116/parental, CoCL2 |
Characteristics
| Age | 48 years |
|---|---|
| Gender | Male |
| Ethnicity | Caucasian |
| Growth properties | Adherent |
Regulatory Data
| Citation | HCT116-GFP (Cytion catalog number 305649) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_0291 |
| GMO Status | GMO-S1: This HCT116 colorectal carcinoma line contains a GFP construct enabling fluorescent monitoring of tumor-cell behavior. This classification applies only within Germany and may differ elsewhere. |
Biomolecular Data
| Mutational profile | Mutation: p.Lys437Argfs*5, Homozygous; Mutation: p.Ile2675Aspfs*6, Heterozygous; Mutation: p.Arg24Serfs*20, Heterozygous; Mutation: p.Glu33Argfs*20, Heterozygous; Mutation: p.Asp74fs*21, Heterozygous; Mutation: p.Ser45del, Heterozygous; Mutation: p.Met1470Cysfs*22, Heterozygous; Mutation: p.Asn1700Thrfs*9, Heterozygous; Mutation: p.Gly13Asp, Heterozygous; Mutation: p.His1047Arg, Heterozygous; Mutation: p.Leu450Ter, Heterozygous; Mutation: p.Lys128Serfs*35, Homozygous |
|---|
Handling
| Culture Medium | McCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Doubling time | 27 hours ; 17.1 hours ; 22 hours ; 25.02 hours ; 36 hours ; 18.14 +- 0.051 hours ; ~25-48 hours ; 17.4 hours ; ~21 hours |
| Seeding density | 2 to 4 x 104 cells/cm2 |
| Freeze medium | As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305649-040326 | Certificate of Analysis | 08. Apr. 2026 | 305649 |